Introduction
Stress physiology: clinical implications
Selhub E
Mechanisms in hemostasis and thrombosis – I
Monitoring hemostasis under flow conditions I
Canu P, Santomaso A, Mazzucato M, De Marco L
Monitoring hemostasis under flow conditions II
De Marco L, Mazzucato M
Mechanisms of platelet activation by agonists
De Candia E
Investigation of platelet defects
Cattaneo M
PAI-1 deficiency and bleeding
Schulman S, Agren A
Biological and clinical consequences of myh9 mutations
Balduini CL
Animal models in platelet pathophysiology
Gresele P
Platelet-leukocyte interaction: a link between thrombosis and inflammation
Cerletti
Aspirin resistance: is this term meaningful?
Violi F
Treatment of hemorrhagic disorders
Treatment of hemorrhagic disorders: cerebral hemorrhage
Marietta M, Pedrazzi P, Torelli G
Acquired hemophilia
Baudo F
Desmopressin
Cattaneo M
Hemostasis and thrombosis in cancer
Factors contributing to the hypercoagulable state in cancer patients
Falanga A
Emerging links between thrombosis, inflammation and cancer: role of heparins
Mousa SA
Molecular biology of thrombosis: present and future
Bernardi F
Screening for venous thombophilia: pros
Simioni P, Tormene D, Spiezia L, Tognin G, Radu C, Rossetto V, Chiriu A, Pagnan A, Prandoni P
No indication for thrombophilia screening
Middeldorp S
Screening for arterial thrombophilia
Margaglione M, Santacroce R
Screening for arterial thrombophilia
Prisco D
Vena cava filters
Prins M
Prophylaxis and treatment of thromboembolism
The First Ambulatory Screening on Thromboembolism (FAST):
a multicentre, cross-sectional, observational study on risk
factors for venous thromboembolism
Di Minno G, Mannuccio Mannucci P, Tufano A, Palareti G, Moia M, Baccaglini U,
Di Minno MND
The optimal duration of oral anticoagulant therapy in patients with venous thromboembolism
Prandoni P
Residual venous obstruction and D-dimer as predictors of recurrent venous thromboembolism
Ageno W
Prophylaxis of venous thromboembolism in orthopedic surgery
Eriksson BI
New anticoagulant drugs in venous and arterial thrombosis
Turpie AGG
Areas of certainty — and uncertainty — about best dosages of new anticoagulants
Davidson B
Mechanisms in Hemostasis and Thrombosis - II
The interactions between inflammation and coagulation
Esmon CT
Expression and regulation of endothelial protein C receptor in monocyte-derived dendritic cells
Faioni EM, Tagliavacca L, Ferrero S, Gianelli U, Fontana G, Cattaneo M
Hyperhomocysteinemia: still a target for intervention?
Autoimmune thrombosis
D’Angelo A, Esmon NL
Mechanisms in Hemostasis and Thrombosis - III
Tissue factor, platelets and polyphosphate: new ways to modulate blood clotting and fibrinolysis
Morrissey JH, Mutch NJ, Smith SA, Waters EK, Docampo R
Thrombin generation: agonists and antagonists
Esmon CT
Factor V: a Janus-faced actor of blood coagulation
Dahlback B
Thrombin signaling in hemostasis and thrombosis
Coughlin S
Mechanisms in Hemostasis and Thrombosis - IV
Platelets and atherothrombosis: new molecular insights
Camera M, Brambilla M, Colnago D, Gertow K, Demetrio M, Marenzi GC,
Biglioli P, Tremoli E
Endothelial progenitor cells for vascular repair and tumor angiogenesis
Barosi G
Circulating endothelial cells and endothelial progenitor cells: two sides of the same coin,
or two different coins?
Blann A
Fibrinolysis and thrombosis
Colucci M, Semeraro N
Coagulation across disciplines
The case of cerebrovascular disease
Sessa M
Thrombophilia and thrombosis in pregnancy
Brenner B
Thrombophilia and pregnancy loss
Grandone E, Colaizzo D, Tiscia G, Cappucci F, Vergura P, Cocomazzi N, Margaglione M
The ATIII EPAS Study
Valsecchi L, D’Angelo A
Comparison of 3 different analytic methods for the measurement of plasma pyridoxal
5-phosphate
Fermo I, Mazzola G, Sampietro F, D’Angelo A
Long-term outcomes of post-surgical deep vein thrombosis in Asia: the aida-extension study
Piovella F, Wang C-J, Lee LH, Lee WC, Turpie AGG, Gallus A, Planes A, Barone M, Beltrametti C, Passera R
Rates of clinically overt venous thromboembolism and death resulting from pulmonary embolism among unselected hospitalized acutely ill medical patients
vs. rates predicted from clinical studies
Piovella F, Anderson FA, Jr., Decousus H, FitzGerald G, Bergmann J-F, Kakkar AK, Spyropoulos AC, Zotz RB, Spencer FA, Turpie AGG, for the IMPROVE Investigators
Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma
Rezaie AR
Evaluation of polymorphisms of genes involved in folate metabolism in patients affected by the Down syndrome
Sampietro F, Scala I, Granese B, Fermo I, D'Angelo A, Andria G
Pharmacokinetic properties of antithrombin concentrate (atIII Kedrion®) supplementation in patients with congenital antithrombin deficiency
Della Valle P, Tormene D, Guazzini S, Bacci M, Simioni P, D’Angelo A
Lipoprotein(A), fibrinogen and vascular mortality in an elderly northern Italian population
D’Angelo A, Ruotolo G, Garancini P, Sampietro F, Mazzola G, Calori G
Disappearance of anti-PF4/heparin antibodies under prolonged fondaparinux administration in a patient with Dvt associated with lmwh-induced thrombocytopenia
Crippa L, Della Valle P, Fattorini A, D'Angelo A
Rare cases of congenital dysfibrinogenemias and thrombophilia in children with deep vein
thrombosis
Sturov VG, Chuprova AV
Dysfibrinogenemias in children: problems of diagnostics, verification and treatment
Sturov VG, Chuprova AV